Clinical Trials Directory

Trials / Unknown

UnknownNCT05179967

Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study)

Guo's visceRal artEries Reconstruction :The Prospective, Multiple Center, Objective Performance Criteria Clinical Trial About the sAfTy and Efficacy of WeFlow-JAAATM Stent Graft System.(GREAT Study)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
106 (estimated)
Sponsor
Hangzhou Endonom Medtech Co., Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A prospective, multi-center, objective performance criteria clinical trial to evaluate the safety and efficacy of WeFlow-JAAA stent graft system manufactured by Hangzhou Endonom Medtech Co., Ltd. for the complex abdominal aortic aneurysm.

Conditions

Interventions

TypeNameDescription
DEVICEWeFlow-JAAA Stent Graft SystemWeFlow-JAAA Stent Graft System consists of abdominal main body of inner embedded stent graft , abdominal main bifurcation stent graft, extension stent graft and branch stent graft. The abdominal main body of inner embedded stent graft is composed of abdominal main embedded covered stent and conveyor, the abdominal main bifurcated stent graft is composed of abdominal main bifurcated stent and conveyor, the extended stent is composed of extended stent graft and conveyor, and the branch vascular stent graft is composed of branch vascular stent and conveyor. The abdominal main body of inner embedded stent graft, abdominal main bifurcation stent graft, extension stent graft and branch vascular stent graft are pre-installed in the corresponding conveyor respectively.

Timeline

Start date
2022-02-23
Primary completion
2022-12-31
Completion
2023-12-31
First posted
2022-01-06
Last updated
2022-03-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05179967. Inclusion in this directory is not an endorsement.